Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Phillip Scheinberg

Showing results (1-10 of 130) with videos related to

Pageof 13
Sort By:
British Journal of Haematology|February 8, 2020
In search for a haemoglobin threshold in myelodysplastic syndromesPhillip Scheinberg
Hematology. American Society of Hematology. Education Program|December 4, 2018
Activity of eltrombopag in severe aplastic anemiaPhillip Scheinberg
The New England Journal of Medicine|January 5, 2022
A New Standard Immunosuppression Regimen in Severe Aplastic AnemiaPhillip Scheinberg
The Lancet. Haematology|September 3, 2019
Stem cell stimulation continues to pay off in aplastic anaemiaPhillip Scheinberg
Cytotherapy|August 26, 2010
Immunosuppression or immunostimulation for aplastic anemia? A blast from the pastPhillip Scheinberg
International Journal of Hematology|May 3, 2013
Prognostic value of telomere attrition in patients with aplastic anemiaPhillip Scheinberg
International Journal of Hematology|February 25, 2024
Progress in medical therapy in aplastic anemia: why it took so long?Phillip Scheinberg
Blood Advances|November 15, 2018
Activity of eltrombopag in severe aplastic anemiaPhillip Scheinberg
The Lancet. Haematology|May 25, 2024
Eltrombopag-cyclosporin A in treating severe aplastic anaemia - Authors' replyPhillip Scheinberg
Cytotherapy|June 5, 2013
Mesenchymal stromal cells: filling the void of immunosuppressive therapy in aplastic anemia?Phillip Scheinberg
Pageof 13

Showing results (1-10 of 130) with videos related to

Sort By:
Pageof 13
British Journal of Haematology|February 8, 2020
In search for a haemoglobin threshold in myelodysplastic syndromesPhillip Scheinberg
Hematology. American Society of Hematology. Education Program|December 4, 2018
Activity of eltrombopag in severe aplastic anemiaPhillip Scheinberg
The New England Journal of Medicine|January 5, 2022
A New Standard Immunosuppression Regimen in Severe Aplastic AnemiaPhillip Scheinberg
The Lancet. Haematology|September 3, 2019
Stem cell stimulation continues to pay off in aplastic anaemiaPhillip Scheinberg
Cytotherapy|August 26, 2010
Immunosuppression or immunostimulation for aplastic anemia? A blast from the pastPhillip Scheinberg
International Journal of Hematology|May 3, 2013
Prognostic value of telomere attrition in patients with aplastic anemiaPhillip Scheinberg
International Journal of Hematology|February 25, 2024
Progress in medical therapy in aplastic anemia: why it took so long?Phillip Scheinberg
Blood Advances|November 15, 2018
Activity of eltrombopag in severe aplastic anemiaPhillip Scheinberg
The Lancet. Haematology|May 25, 2024
Eltrombopag-cyclosporin A in treating severe aplastic anaemia - Authors' replyPhillip Scheinberg
Cytotherapy|June 5, 2013
Mesenchymal stromal cells: filling the void of immunosuppressive therapy in aplastic anemia?Phillip Scheinberg
Pageof 13